Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Payables (2016 - 2025)

Historic Payables for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $133.3 million.

  • Phibro Animal Health's Payables rose 3403.99% to $133.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $133.3 million, marking a year-over-year increase of 3403.99%. This contributed to the annual value of $138.2 million for FY2025, which is 6151.2% up from last year.
  • Phibro Animal Health's Payables amounted to $133.3 million in Q4 2025, which was up 3403.99% from $130.6 million recorded in Q3 2025.
  • Over the past 5 years, Phibro Animal Health's Payables peaked at $138.2 million during Q2 2025, and registered a low of $62.8 million during Q1 2021.
  • Moreover, its 5-year median value for Payables was $86.0 million (2023), whereas its average is $91.7 million.
  • Its Payables has fluctuated over the past 5 years, first crashed by 2274.47% in 2023, then skyrocketed by 6151.2% in 2025.
  • Phibro Animal Health's Payables (Quarter) stood at $80.7 million in 2021, then dropped by 0.22% to $80.5 million in 2022, then rose by 7.36% to $86.4 million in 2023, then increased by 15.09% to $99.4 million in 2024, then surged by 34.04% to $133.3 million in 2025.
  • Its last three reported values are $133.3 million in Q4 2025, $130.6 million for Q3 2025, and $138.2 million during Q2 2025.